These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26935918)

  • 1. Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system.
    Suda Y; Fukushi S; Tani H; Murakami S; Saijo M; Horimoto T; Shimojima M
    Arch Virol; 2016 Jun; 161(6):1447-54. PubMed ID: 26935918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
    Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
    Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay.
    Kinoshita H; Yamada S; Ogawa T; Nguyen PHA; Harada S; Kawahara M; Ishijima K; Maeda K; Ebihara H; Fukushi S
    mBio; 2024 Jul; 15(7):e0109224. PubMed ID: 38847539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crimean-Congo hemorrhagic fever virus replication imposes hyper-lipidation of MAP1LC3 in epithelial cells.
    Moroso M; Verlhac P; Ferraris O; Rozières A; Carbonnelle C; Mély S; Endtz HP; Peyrefitte CN; Paranhos-Baccalà G; Viret C; Faure M
    Autophagy; 2020 Oct; 16(10):1858-1870. PubMed ID: 31905032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Glycoprotein-Mediated Entry of Severe Fever with Thrombocytopenia Syndrome Virus.
    Tani H; Shimojima M; Fukushi S; Yoshikawa T; Fukuma A; Taniguchi S; Morikawa S; Saijo M
    J Virol; 2016 Jun; 90(11):5292-5301. PubMed ID: 26984731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
    Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
    Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crimean-Congo hemorrhagic fever virus activates endothelial cells.
    Connolly-Andersen AM; Moll G; Andersson C; Akerström S; Karlberg H; Douagi I; Mirazimi A
    J Virol; 2011 Aug; 85(15):7766-74. PubMed ID: 21632768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis.
    Nasirian H
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101429. PubMed ID: 32062190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.
    Zivcec M; Scholte FE; Spiropoulou CF; Spengler JR; Bergeron É
    Viruses; 2016 Apr; 8(4):106. PubMed ID: 27110812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.
    Weidmann M; Avsic-Zupanc T; Bino S; Bouloy M; Burt F; Chinikar S; Christova I; Dedushaj I; El-Sanousi A; Elaldi N; Hewson R; Hufert FT; Humolli I; Jansen van Vuren P; Koçak Tufan Z; Korukluoglu G; Lyssen P; Mirazimi A; Neyts J; Niedrig M; Ozkul A; Papa A; Paweska J; Sall AA; Schmaljohn CS; Swanepoel R; Uyar Y; Weber F; Zeller H
    J Gen Virol; 2016 Nov; 97(11):2799-2808. PubMed ID: 27667586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
    Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
    Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crimean-Congo Hemorrhagic Fever.
    Shayan S; Bokaean M; Shahrivar MR; Chinikar S
    Lab Med; 2015; 46(3):180-9. PubMed ID: 26199256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus.
    Mears MC; Rodriguez SE; Schmitz KS; Padilla A; Biswas S; Cajimat MNB; Mire CE; Welch SR; Bergeron É; Alabi CA; Porotto M; Bente DA
    Antiviral Res; 2022 Nov; 207():105401. PubMed ID: 36049554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PACS-2 protein and trafficking motifs in CCHFV Gn and Gc cytoplasmic domains govern CCHFV assembly.
    Gautam A; Lalande A; Ritter M; Freitas N; Lerolle S; Canus L; Amirache F; Lotteau V; Legros V; Cosset FL; Mathieu C; Boson B
    Emerg Microbes Infect; 2024 Dec; 13(1):2348508. PubMed ID: 38661085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.
    Devignot S; Bergeron E; Nichol S; Mirazimi A; Weber F
    J Virol; 2015 Jun; 89(11):5957-67. PubMed ID: 25810550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators.
    Shtanko O; Nikitina RA; Altuntas CZ; Chepurnov AA; Davey RA
    PLoS Pathog; 2014 Sep; 10(9):e1004390. PubMed ID: 25233119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.